TrialAnnals of hematology2021

Prognosis and risk factors for central nervous system relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia.

Qi Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.